Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hofer

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Wiener Klinische Wochenschrift|August 29, 2022
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)Eva Rath, Michael Bonelli, Christina Duftner, et al.
Zeitschrift Fur Rheumatologie|November 7, 2022
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]Eva Rath, Michael Bonelli, Christina Duftner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2022
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter StudyGeorg Semmler, Alexander Lindorfer, Benedikt Schäfer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2017
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatmentKarin Kozbial, Stephan Moser, Ramona Al-Zoairy, et al.
Gastroenterology|December 24, 2011
Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infectionSandra Beinhardt, Judith H Aberle, Michael Strasser, et al.
Infectious Diseases and Therapy|June 14, 2021
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/PibrentasvirAlessio Aghemo, Yves Horsmans, Stefan Bourgeois, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Simplified criteria for the diagnosis of autoimmune hepatitisElke M Hennes, Mikio Zeniya, Albert J Czaja, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Wiener Klinische Wochenschrift|June 26, 2023
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Wiener Klinische Wochenschrift|August 29, 2022
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)Eva Rath, Michael Bonelli, Christina Duftner, et al.
Zeitschrift Fur Rheumatologie|November 7, 2022
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]Eva Rath, Michael Bonelli, Christina Duftner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2022
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter StudyGeorg Semmler, Alexander Lindorfer, Benedikt Schäfer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2017
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatmentKarin Kozbial, Stephan Moser, Ramona Al-Zoairy, et al.
Gastroenterology|December 24, 2011
Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infectionSandra Beinhardt, Judith H Aberle, Michael Strasser, et al.
Infectious Diseases and Therapy|June 14, 2021
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/PibrentasvirAlessio Aghemo, Yves Horsmans, Stefan Bourgeois, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Simplified criteria for the diagnosis of autoimmune hepatitisElke M Hennes, Mikio Zeniya, Albert J Czaja, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Wiener Klinische Wochenschrift|June 26, 2023
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Pageof 8